A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19

NCT04605588 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Lack of participants willing to enroll

Conditions

SARS-CoV Infection
Covid19

Interventions

DRUG: Nitazoxanide
DRUG: Placebo Nitazoxanide
DRUG: Ribavirin
DRUG: Placebo Ribavirin
DRUG: Hydroxychloroquine
DRUG: Placebo Hydroxychloroquine

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]